Skip to content

NAVIDEA BIOPHARMACEUTICALS, INC.

Delisted

CIK 810509fmd_0QXF3FW726K0BVVWRQQH6VG8S8Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2023, 55 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading